Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Eden Biodesign | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Eden Biodesign

Dr. Derek Ellison was appointed chief operating officer, Eden Biodesign.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Derek Ellison was appointed chief operating officer, Eden Biodesign. The appointment is part of a management restructure, changing responsibilities for seven executive and senior management members to support the company’s expansion efforts.
 
Dr. Ellison, co-founder of Eden and previously vice president development and manufacturing, stated, “I am extremely excited to take on the role of COO. Being a co-founder of Eden, I have witnessed the company rise and develop, and am extremely proud of our move into new markets, while retaining our excellent reputation.”
 
Dr. Anita Bate, co-founder of Eden and previously science director, will become chief scientific officer. Dr. Bate’s responsibilities will include managing a transatlantic team tasked with exploring new opportunities for the company and evaluating new technologies.
 
Also, as Dr. Phil Ball moves from the UK to the U.S. offices, he will take up the role of technical director and will support Roger Lias, president of Eden Biodesign, Inc. (the U.S. subsidiary of Eden).
 
Additional promotions and changes in responsibility include:  Dr. David Simpson, process development manager, Dr. Mandy Shipman, biopharm development consultant, and Gina Wenham will take on responsibility for the Analytical Development team alongside Quality Control and Alison Justice has been promoted to QA director.
 
Dr. Crawford Brown, chief executive officer and founder of Eden Biodesign commented, “We are delighted to announce these strategic changes to the executive and senior management team, which will maintain Eden’s position of leadership in the bioprocessing marketplace and which demonstrates our commitment to U.S. development and our international focus as demand continues to grow.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics